InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Roberts Christopher D., Directeur Scientifique. Insider active across 1 companies, notably Black Diamond Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€22,5102,500 shares@ €9.004100.0% of flow
Common Stock
SEC:0000899243-21-018358·
€22,5102,500 shares@ €9.0040.016% mcap50.0% of flow
Common Stock
SEC:0000899243-21-018358:0·
2 of 2 declarations
About Roberts Christopher D.
Roberts Christopher D. is the Chief Scientific Officer of Black Diamond Therapeutics, Inc. In this role, he is responsible for research and development of new treatments, contributing to innovation in the biopharmaceutical sector.
